. Antiviral drug ensitrelvir shows promise in preventing household COVID spread - IOPAC Press "Enter" to skip to content

Third meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024
- All WHO news
<p>The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third meeting of the International...
Nearly 50 million people sign up call for clean air action for better health
- All WHO news
<p>In an unprecedented show of unity, more than 47 million health professionals, patients, advocates, representatives from civil society organizations, and...
UN Commission approves WHO recommendations to place psychoactive substances under international control
- All WHO news
Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Antiviral drug ensitrelvir shows promise in preventing household COVID spread

By iopac on March 19, 2025

A total of 9% of placebo recipients contracted COVID-19 from a household member, compared with 3% of ensitrelvir recipients, for a 67% risk reduction.

Published in COVID-19

iopac

More from COVID-19More posts in COVID-19 »